Our results suggested that activation of MEK/ERK1/2 led to stimulation of AMPKα signaling and the reciprocal interaction of MEK/ERK1/2 and AMPKα signaling pathways contributed to the overall responses of baicalein in the control of lung cancer cell proliferation. Here, MAPK3 is linked to lung carcinoma.